News Room
Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.
Announcements
October 27, 2020
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
Announcements
October 1, 2020
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
Announcements
June 29, 2020
Repligen Announces Agreement to Acquire Engineered Molding Technology
Announcements
April 26, 2019
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies
Announcements
September 4, 2018
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors
Announcements
June 28, 2018
Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand
Announcements
June 27, 2018
Repligen Announces Agreement with Navigo Proteins for the Exclusice Co-Development of Next Generation Affinity Ligands
Announcements
June 23, 2017
Repligen Corporation and Spectrum Inc. to Join Forces
Announcements
December 15, 2016
Repligen acquires TangenX Technology Corporation
Announcements
October 4, 2016
Repligen Launches Single-Use XCell™ ATF System for Bioprocess Intensification
Announcements
April 4, 2016